Axl-Targeted Cancer Imaging with Humanized Antibody h173

PET Imaging of Colorectal and Breast Cancer by Targeting EphB4 Receptor with 64Cu-Labeled hAb47 and hAb131 Antibodies

(2013) S. Liu et al.   JOURNAL OF NUCLEAR MEDICINE

EphB4-Targeted Imaging with Antibody h131, h131-F(ab′)2 and h131-Fab

(2013) Dan Li et al.   MOLECULAR PHARMACEUTICS

Antibody-Conjugated Nanoparticles for Therapeutic Applications

(2012) M. M. Cardoso et al.   CURRENT MEDICINAL CHEMISTRY

Therapeutic targets and recent advances in protein immunotoxins

(2012) Madhumathi J et al.   CURRENT OPINION IN MICROBIOLOGY

Efficient Construction of PET/Fluorescence Probe Based on Sarcophagine Cage: An Opportunity to Integrate Diagnosis with Treatment

(2012) Shuanglong Liu et al.   MOLECULAR IMAGING AND BIOLOGY

Targeting the EphB4 Receptor for Cancer Diagnosis and Therapy Monitoring

(2012) Dan Li et al.   MOLECULAR PHARMACEUTICS

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

(2012) Zhenfeng Zhang et al.   NATURE GENETICS

Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor Kinase

(2011) Marialuisa Sensi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Targeting Axl and Mer Kinases in Cancer

(2011) A. Verma et al.   MOLECULAR CANCER THERAPEUTICS

PET/NIRF/MRI triple functional iron oxide nanoparticles

(2010) Jin Xie et al.   BIOMATERIALS

Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma

(2010) R. Liu et al.   BLOOD

R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer

(2010) S. J. Holland et al.   CANCER RESEARCH

Radioimmunotherapy of Solid Tumors: Searching for the Right Target

(2010) Hong Song et al.   Current Drug Delivery

Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis

(2009) Y Li et al.   ONCOGENE

Axl and Growth Arrest Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme

(2008) M. Hutterer et al.   CLINICAL CANCER RESEARCH